KamalManubhaiBakriMD

PubMed

• 32 citations
  A Randomized Phase II Trial of First-Line Treatment with Gemcitabine, Erlotinib, or Gemcitabine and Erlotinib in Elderly Patients (Age ≥70 Years) with Stage IIIB/IV No...
  Thomas E. Stinchcombe, Amy H. Peterman, Carrie B. Lee, Dominic T. Moore, Jennifer L. Beaumont, Daniel S. Bradford, Kamal Bakri, Mark Taylor, Jeffrey M. Crane, Garry Sc...> ;Journal of Thoracic Oncology. 2011 Sep 1
• 6 citations
  A multicenter phase II trial of carboplatin and cetuximab for treatment of advanced nonsmall cell lung cancer.
  Thomas E. Stinchcombe, Daniel S. Bradford, Thomas A. Hensing, Renato V. LaRocca, Mansoor N. Saleh, Tracey L. Evans, Kamal Bakri, Mark A. Socinski> ;Cancer Investigation. 2009 Sep 30
• 27 citations
  Racial Differences in Clinical Outcomes From Metastatic Breast Cancer: A Pooled Analysis of CALGB 9342 and 9840—Cancer and Leukemia Group B
  Blase N. Polite, C. Cirrincione, Gini F. Fleming, Donald A. Berry, Andrew D. Seidman, Hyman B. Muss, Larry Norton, Charles Shapiro, Kamal Bakri, Kelly Marcom, Diana La...> ;Journal of Clinical Oncology. 2008 Jun 1
• 6 citations
  A phase I/II trial of weekly docetaxel and gefitinib in elderly patients with stage IIIB/IV non-small cell lung cancer.
  Thomas E. Stinchcombe, Petra Bůžková, Janak K. Choksi, Mark Taylor, Kamal Bakri, Heidi H. Gillenwater, Maureen Tynan, A. Mears, Paul Jones, Mark A. Socinski> ;Lung Cancer. 2006 Jun 1
• 34 citations
  A randomized phase II trial comparing every 3-weeks carboplatin/paclitaxel with every 3-weeks carboplatin and weekly paclitaxel in advanced non-small cell lung cancer
  Mark A. Socinski, Anastasia Ivanova, Kamal Bakri, J. Wall, Maria Q. Baggstrom, Thomas A. Hensing, A. Mears, Maureen Tynan, J. Beaumont, Amy H. Peterman, H. B. Niell> ;Annals of Oncology. 2006 Jan 1
• A phase I/II trial of weekly docetaxel and gefitinib in elderly patients (≥ 70) with stage IIIB/IV non-small cell lung cancer (NSCLC).
  Stinchcombe TE, Socinski MA, Choksi J, Bakri K, Taylor M, Tynan MT, Mears A, Smith C> ;J. Clin. Oncol.. 2005-06-01
• Randomized phase II trial comparing every-3-week carboplatin/paclitaxel (C/P) versus every-3-week C with weekly P in advanced non-small cell lung cancer (NSCLC).
  Niell HB, Socinski MA, Bakri K, Wall J, Baggstrom M, Escudero M, Mears A, Tynan M, Ivanova A> ;J. Clin. Oncol.. 2004-07-15
• 44 citations
  Second-line, low-dose, weekly paclitaxel in patients with stage IIIB/IV nonsmall cell lung carcinoma who fail first-line chemotherapy with carboplatin plus paclitaxel.
  Mark A. Socinski, Michael J. Schell, Kamal Bakri, Amy H. Peterman, Ji-Hyun Lee, Paul Unger, Steven Yates, Stacie Hudgens, Merrill S. Kies> ;Cancer. 2002 Sep 15
• Polyarthritis and neutropenia.
  Kamal M. Bakri> ;Annals of Internal Medicine. 1986 Jan 1
• 18 citations
  T-suppressor cell chronic lymphocytic leukemia. Phenotypic characterization by monoclonal antibodies
  Kamal M. Bakri, Ediz Z. Ezdinli, Larry P. Wasser, Tin Han, Thomas Sinclair, Satinder Singh, Howard Ozer, Jun Minowada> ;Cancer. 1984 Jul 15
• 3 citations
  Association of thyroid carcinoma with malignant lymphoma.
  Bakri Km, Shimaoka K, Gajera R, Getaz Ep, Friedman M, Walsh D, Tsukada Y> ;Japanese Journal of Clinical Oncology. 1983 Dec 1
• 11 citations
  Adenosquamous carcinoma of the thyroid after radiotherapy for Hodgkin's disease. A case report and review.
  Kamal Bakri, Katsutaro Shimaoka, U. Rao, Yoshiaki Tsukada> ;Cancer. 1983 Aug 1
• Trimethoprim-sulfamethoxazole and granulocytopenia
  Kamal M. Bakri, Larry P. Wasser> ;Annals of Internal Medicine. 1982 Mar 1
• Phase III trial comparing a defined duration of therapy versus continuous therapy followed by second-line therapy in advanced-stage IIIB/IV non-small-cell lung cancer.
  Socinski, M. A., Schell, M. J., Peterman, A., Bakri, K., Yates, S., Gitten, R., Unger, P., Lee, J., Lee, J. H., Tynan, M., Moore, M., Kies, M. S.> ;J Clin Oncol. 2002 Mar 1
• Join now to see all